PathoQuest appoints Dr Colette Côté as General Manager of U.S. subsidiary and Chief Portfolio Officer
Posted on March 25, 2021
In her role as Chief Portfolio Officer, Colette will bring next-generation sequencing (NGS) further into the market by developing the portfolio of NGS-based biosafety and genetic characterization services addressing the biopharmaceutical and biotech companies’ needs. To further support the rapid expansion of PathoQuest footprint in the US, she will also endorse the role of General Manager of the site in Wayne, PA, where she will oversee the buildout of the lab, the recruitment of the experts’ team, and work on the certification of this facility. As a renowned NGS expert in the biopharmaceutical industry, she will advance our NGS-based biologics testing business further especially on the North American, a prime target of PathoQuest.
Related Topics and Keywords
Colette Côté, next generation sequencing, NGS, PathoQuest
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
